Cardiorenal Med. 2026 Jun 4:1-12. doi: 10.1159/000552830. Online ahead of print.
ABSTRACT
Cardiovascular-kidney-metabolic (CKM) syndrome integrates the strong interrelationship among cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors such as obesity and diabetes. Renal replacement therapy (RRT) is considered an essential component of management in advanced CKD. Kidney failure has unique therapeutic and prognostic challenges, particularly with co-existence of heart failure, ischemic heart disease and metabolic syndrome. In this review, we aim to evaluate challenges and therapeutic considerations in dialytic therapies and kidney transplantation in patients with CKM syndrome.
PMID:42241368 | DOI:10.1159/000552830